Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, with reference to the Answer of 19 January 2012, Official Report, columns 932-3W, how many companies hold licences for the manufacture or distribution of (a) Nitrazepam, (b) Flurazepam, (c) Loprazolam, (d) Lormetazepam, (e) Temazepam, (f) Clonazepam, (g) Medazepam, (h) Midazolam, (i) Zopiclone, (j) Zaleplon, (k) Zolpiden, (l) Eszopiclone, (m) SSRI antidepressants and (n) trycyclic antidepressants; and how many of those licences were issued in the last three years.

There are currently 15 products authorised in the United Kingdom containing nitrazepam and 15 different companies authorised to manufacture and distribute them.

There are currently two products authorised in the UK containing flurazepam and one company authorised to manufacture and distribute them.

There are currently two products authorised in the UK containing loprazolam and two different companies authorised to manufacture and distribute them.

There are currently eight products authorised in the UK containing lormetazepam and four different companies authorised to manufacture and distribute them.

There are currently 10 products authorised in the UK containing temazepam and six different companies authorised to manufacture and distribute them.

There are currently six products authorised in the UK containing clonazepam and three different companies authorised to manufacture and distribute them.

There are currently no authorised products in the UK containing medazepam.

There are currently 22 products authorised in the UK containing midazolam and 10 different companies authorised to manufacture and distribute them.

There are currently 17 products authorised in the UK containing zopiclone and nine different companies authorised to manufacture and distribute them.

There are currently two products authorised in the UK containing zaleplon and one company authorised to manufacture and distribute them.

There are currently 21 products authorised in the UK containing zolpidem and 12 different companies authorised to manufacture and distribute them.

There are currently no authorised products in the UK containing eszopiclone.

There are currently 238 products authorised in the UK containing SSRI antidepressants and 57 different companies authorised to manufacture and distribute them.

There are currently 16 products authorised in the UK containing tricyclic antidepressants and 11 different companies authorised to manufacture and distribute them.

One loprazolam, four lormetazepam, two clonazepam, two midazolam, three zopiclone, four zolpidem and 75 SSRI products have been authorised in the last three years.